Why Manufacturing Still Matters
The post-industrial thesis held that advanced economies could prosper on services alone. The pandemic, the supply chain crisis, and the return of great-power competition have rendered that thesis untenable.
The assembly line at the Stellantis complex in Sterling Heights, Michigan, produces approximately 1,200 vehicles per day through a process that combines robotic precision with human judgment in proportions that have shifted steadily toward the former over the past three decades. The plant employs 4,800 workers, down from 8,200 in 1998, while producing forty percent more vehicles. These numbers, which manufacturing's critics cite as evidence of the sector's diminishing relevance to employment, actually demonstrate something quite different: that manufacturing's value to a national economy is not reducible to headcount. The workers who remain are among the most productive — and best compensated — in the American labor force, and the industrial ecosystem that surrounds them supports roughly four additional jobs for every position on the factory floor.
The post-industrial thesis that dominated economic thinking from the 1990s through the pre-pandemic era held that advanced economies could safely offshore manufacturing while retaining the higher-value activities of design, marketing, and finance. The thesis was elegant, intellectually satisfying, and wrong. Its error was not economic but strategic: it assumed a geopolitical environment in which supply chains would remain frictionless and trading partners would remain cooperative indefinitely. The pandemic, which revealed the consequences of depending on foreign manufacturing for essential medical supplies, and the deterioration of U.S.-China relations, which raised the specter of supply chain weaponization, have exposed the post-industrial thesis as a peacetime luxury.
The national security argument for domestic manufacturing has become, in the current geopolitical climate, essentially unanswerable. The Department of Defense relies on commercial semiconductor fabrication for advanced weapons systems. The pharmaceutical industry sources approximately eighty percent of active pharmaceutical ingredients from overseas manufacturers, predominantly in China and India. The domestic capacity to produce artillery shells — a concern that seemed anachronistic before the war in Ukraine — has proven insufficient to sustain even indirect participation in a conventional conflict. These dependencies are not market failures; they are the predictable consequences of a deliberate national strategy to prioritize consumption efficiency over production resilience.
From the Publisher
The Commonwealth Times is sustained not by advertisers, algorithms, or attention merchants, but by the conviction of its readers. What you have begun to read represents the work of correspondents, editors, and scholars who believe that journalism, practiced with rigor and presented with dignity, remains essential to the health of the Republic. We invite you to join our Society of Patrons and ensure that this work endures.
The economic case, while less dramatic than the strategic one, is equally compelling. Manufacturing generates more research and development spending per dollar of revenue than any other sector. It produces more patents, trains more engineers, and creates more opportunities for workers without college degrees to earn middle-class incomes. The hollowing out of American manufacturing did not merely eliminate factory jobs; it eliminated the economic ecosystem that sustains technical education, applied research, and the diffusion of practical knowledge through communities. Rebuilding that ecosystem is the work of a generation. The alternative — continued dependence on foreign manufacturing for essential goods in an era of great-power competition — is a risk that no serious strategist would willingly accept.